Benjamin Hickey - 16 Jan 2024 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role
EVP, Chief Commercial Officer
Signature
/s/ John Moriarty, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 Jan 2024
Net transactions value
-$94,255
Form type
4
Filing time
18 Jan 2024, 16:45:36 UTC
Previous filing
09 Jan 2024
Next filing
23 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale $57,013 -966 -0.81% $59.02 117,659 16 Jan 2024 Direct F1
transaction MRTX Common Stock Sale $37,242 -631 -0.54% $59.02 117,028 16 Jan 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 14, 2022.
F2 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 15, 2021.